Association of COPD Maintenance Medication Adherence with Resource Use and Cost among COPD Patients

Trial Identifier:	D2287R00123
Sponsor:	AstraZeneca
NCTID::	NCT03359122
Start Date:	June 2018
Primary Completion Date:	August 2018
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Beijing, China, 100000

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.